Home
Trails Edge Capital Partners reported a 2% stake in Faeth Therapeutics FTH · 515,335 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 2%
- Last report
- 9.9% · filed 26/02/25
- Shares held
- 515,335 sh
- Class
- Common Stock, par value $0.0001 per share
- Event date
- 26/06/30
- Filed
- 26/08/14
2% stake · below 5%
- Stake
- 2%
- Last report
- 9.9%
- Since last report
- −7.9pp
Faeth Therapeutics trades, last 26 weeks
What else happened in Faeth Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Trails Edge Capital Partners's other 5% stake reports
- Trails Edge Capital Partners
5% stakeNeurogene
5% stakeNeurogene
NGNE
4.5% stake
714,885 sh
4.5% stake
Filed 08/14
- Trails Edge Capital Partners
5% stakeOnKure Therapeutics
5% stakeOnKure Therapeutics
OKUR
3.6% stake
1,438,456 sh
3.6% stake
Filed 08/14
- Trails Edge Capital Partners
5% stakeCamp4 Therapeutics
5% stakeCamp4 Therapeutics
CAMP
6% stake
3,790,636 sh
6% stake
Filed 08/10
- Trails Edge Capital Partners
5% stakeResearch Alliance Corp IV
5% stakeResearch Alliance Corp IV
RACD
5.5% stake
500,000 sh
5.5% stake
Filed 07/21
- Trails Edge Capital Partners
5% stakeResearch Alliance Corp III
5% stakeResearch Alliance Corp III
RACC
5.5% stake
500,000 sh
5.5% stake
Filed 05/29
